Changes in the macrophage polarization in the kidneys of rats with acute respiratory distress syndrome after transplantation of human umbilical cord-derived mesenchymal stem cell

Home/2024, Vol. 12, No. 2/Changes in the macrophage polarization in the kidneys of rats with acute respiratory distress syndrome after transplantation of human umbilical cord-derived mesenchymal stem cell

Cell and Organ Transplantology. 2024; 12(2):102-109 (e2024122170)
DOI: 10.22494/cot.v12i2.170

Changes in the macrophage polarization in the kidneys of rats with acute respiratory distress syndrome after transplantation of human umbilical cord-derived mesenchymal stem cell

Palii I., Dovgalyuk A., Kramar S., Korda M.

  • I. Horbachevsky Ternopil National Medical University, Ternopil, Ukraine

Abstract

Acute respiratory distress syndrome (ARDS) is a critical state of the body characterized by severe hypoxemia and multiple organ failure. One of the organs that is most often additionally affected due to the systemic inflammatory reaction that occurs in the lungs during ARDS is the kidney. It is known that mesenchymal stem cells (MSCs) can exhibit nephroprotective effects due to their anti-inflammatory and immunomodulatory abilities, but the mechanisms of such therapeutic effects require further elucidation.
The purpose is to analyze macrophage polarization in the damaged kidneys of rats with modeled ARDS following the transplantation of human umbilical cord-derived MSCs.
Materials and methods. Seventy-two sexually mature male Wistar rats were randomly divided into nine groups: intact animals, 3 days, 7 days and 28 days after ARDS modeling, control-MSC and four correction groups: 24 h ARDS + 2 days MSCs, 4 days of ARDS + 3 days of MSCs, 14 days of ARDS + 14 days of MSCs, 21 days of ARDS + 7 days of MSCs. ARDS was modeled by intranasal administration of lipopolysaccharide (LPS) at a dose of 5 mg/kg. A suspension of MSCs was obtained from the umbilical cord of a healthy donor after a normal delivery by an enzymatic method and administered intraperitoneally at a dose of 1 million cells/kg of body weight. For immunohistochemical determination of the total number of macrophages, pro-inflammatory M1 and anti-inflammatory M2 cells, monoclonal antibodies to CD68, CD86 and CD163 were used, respectively, and the percentage of visual fields occupied by the immunoprecipitate was calculated.
Results. Comparative analysis of the percentage of areas occupied by the immunoprecipitate with the corresponding antibodies showed a statistically significant increase in the total number of macrophages (3.8-fold on day 3 of ARDS, 2.8-fold on day 7 of ARDS and 2.4-fold on day 28 of ARDS, respectively), as well as a sharp increase in pro-inflammatory M1 (8.8-fold on day 3 of ARDS, 4.9-fold on day 7 of ARDS, and 4.8-fold on day 28 of ARDS, respectively) and a moderate increase in the percentage of anti-inflammatory M2 cells (1.9-fold on day 3 of ARDS, 2-fold on day 7 of ARDS, and 1.6-fold on day 28 of ARDS, respectively) in modeled ARDS compared to intact animals. This indicates the activation of the inflammatory cascade in the kidneys caused by the development of ARDS. On the other hand, in groups of animals that received MSC correction, a significant decrease, compared to untreated animals, in the total number of macrophages was detected (at 24 h of ARDS + 2 days of MSCs, it was 3.2 times lower than on day 3 of ARDS and ≥ 2 times at later times of the experiment), among which anti-inflammatory cells of the M2 phenotype predominated.
Conclusion. Transplanted human umbilical cord-derived MSCs have a pronounced immunomodulatory effect in the affected kidneys of rats with acute respiratory distress syndrome, which is manifested in their ability to change the polarization of macrophages in the anti-inflammatory direction.

Keywords: acute respiratory distress syndrome; kidney damage; mesenchymal stem cells; M1 and M2 macrophages


Full text PDF

1. Vashisht R, Duggal A. Acute kidney injury in acute respiratory distress syndrome: why ventilator settings matter. Ann Transl Med. 2020; 8(9):573.
https://doi.org/10.21037/atm-20-2163
PMid:32566600 PMCid:PMC7290557
2. Upadhyaya VD, Shariff MZ, Mathew RO, Hossain MA, Asif A, Vachharajani TJ. Management of Acute Kidney Injury in the Setting of Acute Respiratory Distress Syndrome: Review Focusing on Ventilation and Fluid Management Strategies. J Clin Med Res. 2020; 12(1):1-5.
https://doi.org/10.14740/jocmr3938
PMid:32010415 PMCid:PMC6968920
3. Lee PW, Wu BS, Yang CY, Lee OK. Molecular Mechanisms of Mesenchymal Stem Cell-Based Therapy in Acute Kidney Injury. Int J Mol Sci. 2021; 22(21):11406.
https://doi.org/10.3390/ijms222111406
PMid:34768837 PMCid:PMC8583897
4. Redko OS, Dovgalyuk A. Morphological changes in rat liver during acute respiratory distress syndrome at different periods of experiment. Bulletin of Medical and Biological Research, 2022; 4(4):52-57.
https://doi.org/10.11603/bmbr.2706-6290.2022.4.13317
5. Redko O, Dovgalyuk A, Nebesna Z, Kramar S, Sverstyuk A, Korda M. Human umbilical cord-derived мesenchymal stromal cells mitigate lipopolysaccharide-induced liver injury in rats. Cell Organ Transpl. 2023; 11(1):34-45.
https://doi.org/10.22494/cot.v11i1.148
6. Liu WH, Feng L, Wang X, Wei L, Zou HQ. GDF11 Improves Ischemia-Reperfusion-Induced Acute Kidney Injury via Regulating Macrophage M1/M2 Polarization. Kidney Blood Press Res. 2023; 48(1):209-219.
https://doi.org/10.1159/000529444
PMid:36780878 PMCid:PMC10124752
7. Palii I, Dovgalyuk A. Morphofunctional state of the kidneys of laboratory rats during acute respiratory distress syndrome. Bulletin of Medical and Biological Research, 2023; 5(4): 42-52.
https://doi.org/10.61751/bmbr/4.2023.42
8. Palii I, Dovgalyuk A, Redko O, Dovbush A, Kramar S, Nebesna Z, et al. Morphofunctional changes in the kidneys of rats during acute respiratory distress syndrome and its treatment with human umbilical cord-derived mesenchymal stem cells. Cell Organ Transpl. 2024; 12(1):60-71.
https://doi.org/10.22494/cot.v12i1.166
9. Zilberman-Itskovich S, Efrati S. Mesenchymal Stromal Cell Uses for Acute Kidney Injury-Current Available Data and Future Perspectives: A Mini-Review. Front Immunol. 2020;11:1369.
https://doi.org/10.3389/fimmu.2020.01369
PMid:32793191 PMCid:PMC7385060
10. Zeng J, Zhang Y, Huang C. Macrophages polarization in renal inflammation and fibrosis animal models (Review). Mol Med Rep. 2024; 29(2):29.
https://doi.org/10.3892/mmr.2023.13152
PMid:38131228 PMCid:PMC10784723
11. Ruiz-Ortega M, Rayego-Mateos S, Lamas S, Ortiz A, Rodrigues-Diez RR. Targeting the progression of chronic kidney disease. Nat Rev Nephrol. 2020; 16(5):269-288.
https://doi.org/10.1038/s41581-019-0248-y
PMid:32060481
12. Lee KH, Tseng WC, Yang CY, Tarng DC. The Anti-Inflammatory, Anti-Oxidative, and Anti-Apoptotic Benefits of Stem Cells in Acute Ischemic Kidney Injury. Int J Mol Sci. 2019; 20(14):3529.
https://doi.org/10.3390/ijms20143529
PMid:31330934 PMCid:PMC6678402
13. Cantero-Navarro E, Rayego-Mateos S, Orejudo M, Tejedor-Santamaria L, Tejera-Muñoz A, Sanz AB, et al. Role of Macrophages and Related Cytokines in Kidney Disease. Front Med (Lausanne). 2021; 8:688060.
https://doi.org/10.3389/fmed.2021.688060
PMid:34307414 PMCid:PMC8295566
14. Nachiappa Ganesh R, Garcia G, Truong L. Monocytes and Macrophages in Kidney Disease and Homeostasis. Int J Mol Sci. 2024; 25(7):3763.
https://doi.org/10.3390/ijms25073763
PMid:38612574 PMCid:PMC11012230
15. Liu C, Xiao K, Xie L. Advances in the Regulation of Macrophage Polarization by Mesenchymal Stem Cells and Implications for ALI/ARDS Treatment. Front Immunol. 2022; 13:928134.
https://doi.org/10.3389/fimmu.2022.928134
PMid:35880175 PMCid:PMC9307903
16. Funes SC, Rios M, Escobar-Vera J, Kalergis AM. Implications of macrophage polarization in autoimmunity. Immunology. 2018; 154(2):186-195.
https://doi.org/10.1111/imm.12910
PMid:29455468 PMCid:PMC5980179
17. Ley K. M1 Means Kill; M2 Means Heal. J Immunol. 2017; 199(7):2191-2193.
https://doi.org/10.4049/jimmunol.1701135
PMid:28923980
18. Arabpour M, Saghazadeh A, Rezaei N. Anti-inflammatory and M2 macrophage polarization-promoting effect of mesenchymal stem cell-derived exosomes. Int Immunopharmacol. 2021; 97:107823.
https://doi.org/10.1016/j.intimp.2021.107823
PMid:34102486
19. Babazadeh S, Nassiri SM, Siavashi V, Sahlabadi M, Hajinasrollah M, Zamani-Ahmadmahmudi M. Macrophage polarization by MSC-derived CXCL12 determines tumor growth. Cell Mol Biol Lett. 2021; 26(1):30.
https://doi.org/10.1186/s11658-021-00273-w
PMid:34174813 PMCid:PMC8236206
20. Fan X, Li L, Ye Z, Zhou Y, Tan WS, Yang J. Advances in umbilical cord mesenchymal stem cells: A review of their potential in regenerative medicine. Expert Opin Biol Ther. 2021; 21(10):1355-1366. https://doi.org/10.1080/14712598.2021.1921837
21. Cao X, Duan L, Hou H, Liu Y, Chen S, Zhang S, et al. IGF-1C hydrogel improves the therapeutic effects of MSCs on colitis in mice through PGE2-mediated M2 macrophage polarization. Theranostics. 2020; 10(17):7697-7709.
https://doi.org/10.7150/thno.45434
PMid:32685014 PMCid:PMC7359093
22. Zhang Y, Le X, Zheng S, Zhang K, He J, Liu M, et al. MicroRNA-146a-5p-modified human umbilical cord mesenchymal stem cells enhance protection against diabetic nephropathy in rats through facilitating M2 macrophage polarization. Stem Cell Res Ther. 2022; 13(1):171.
https://doi.org/10.1186/s13287-022-02855-7
PMid:35477552 PMCid:PMC9044847
23. Krynytska I, Marushchak M, Birchenko I, Dovgalyuk A, Tokarskyy O. COVID-19-associated acute respiratory distress syndrome versus classical acute respiratory distress syndrome (a narrative review). Iran J Microbiol. 2021; 13(6):728-738.
https://doi.org/10.18502/ijm.v13i6.8072
PMid:35222850 PMCid:PMC8816697
24. Fernández-Francos S, Eiro N, González-Galiano N, Vizoso FJ. Mesenchymal Stem Cell-Based Therapy as an Alternative to the Treatment of Acute Respiratory Distress Syndrome: Current Evidence and Future Perspectives. Int J Mol Sci. 2021; 22(15):7850.
https://doi.org/10.3390/ijms22157850
PMid:34360616 PMCid:PMC8346146
25. Sanabria-de la Torre R, Quiñones-Vico MI, Fernández-González A, Sánchez-Díaz M, Montero-Vílchez T, Sierra-Sánchez Á, et al. Alloreactive Immune Response Associated to Human Mesenchymal Stromal Cells Treatment: A Systematic Review. J Clin Med. 2021; 10(13):2991.
https://doi.org/10.3390/jcm10132991
PMid:34279481 PMCid:PMC8269175
26. Chen H, Liu N, Zhuang S. Macrophages in Renal Injury, Repair, Fibrosis Following Acute Kidney Injury and Targeted Therapy. Front Immunol. 2022; 13:934299.
https://doi.org/10.3389/fimmu.2022.934299
PMid:35911736 PMCid:PMC9326079
27. Li N, Chen J, Geng C, Wang X, Wang Y, Sun N, et al. Myoglobin promotes macrophage polarization to M1 type and pyroptosis via the RIG-I/Caspase1/GSDMD signaling pathway in CS-AKI. Cell Death Discov. 2022; 8(1):90.
https://doi.org/10.1038/s41420-022-00894-w
PMid:35228524 PMCid:PMC8885737
28. Xie X, Yang X, Wu J, Tang S, Yang L, Fei X, et al. Exosome from indoleamine 2,3-dioxygenase-overexpressing bone marrow mesenchymal stem cells accelerates repair process of ischemia/reperfusion-induced acute kidney injury by regulating macrophages polarization. Stem Cell Res Ther. 2022; 13(1):367.
https://doi.org/10.1186/s13287-022-03075-9
PMid:35902956 PMCid:PMC9331485
29. Ren Y, Chen Y, Zheng X, Wang H, Kang X, Tang J, et al. Human amniotic epithelial cells ameliorate kidney damage in ischemia-reperfusion mouse model of acute kidney injury. Stem Cell Res Ther. 2020; 11(1):410.
https://doi.org/10.1186/s13287-020-01917-y
PMid:32967729 PMCid:PMC7510147
30. Redko O, Dovgalyuk A, Kramar S, Ohinska N, Nebesna Z, Korda M. Mesenchymal stem cell therapy modulates macrophage dynamics in ARDS-associated liver injury in rats. Cell Organ Transpl. 2023; 11(2):114-121.
https://doi.org/10.22494/cot.v11i2.157
31. Collino F, Lopes JA, Tapparo M, Tortelote GG, Kasai-Brunswick TH, Lopes GMC, et al. Extracellular Vesicles Derived from Induced Pluripotent Stem Cells Promote Renoprotection in Acute Kidney Injury Model. Cells. 2020; 9(2):453.
https://doi.org/10.3390/cells9020453
PMid:32079274 PMCid:PMC7072760

Palii I, Dovgalyuk A, Kramar S, Korda M. Changes in the macrophage polarization in the kidneys of rats with acute respiratory distress syndrome after transplantation of human umbilical cord-derived mesenchymal stem cell. Cell Organ Transpl. 2024; 12(2):102-109 (e2024122170). doi: https://doi.org/10.22494/cot.v12i2.170

 

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.